Researchers at Stanford University report using artificial intelligence to design new virus candidates, according to multiple outlets. The reporting describes the work as part of efforts to apply AI to virology, with the researchers arguing it could support future development of treatments. The sources characterize the research as early-stage and focused on generating novel viral designs rather than on clinical use or deployment. While the articles emphasize the potential benefits, they also reflect public concern about risks associated with creating new viral entities, underscoring that the study is being discussed in a broader biosecurity context. Across the coverage, the primary points are that the research team is based at Stanford, that AI is used in the design process, and that the researchers say the approach could help enable new therapeutic strategies. The outlets provide limited methodological and outcome details, but agree on the core theme: AI-driven design of virus candidates and the researchers’ stated hope for downstream medical applications.